Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

EssilorLuxottica Shares Hit Two-Year Low Despite Double-Digit Growth

EssilorLuxottica drops 2.58% this Friday morning to 186.85 euros, breaking below its 2024 floor. The stock has fallen nearly 30% over three months, in a Parisian market that is also trending downward, with the CAC 40 declining by 1.05% during the session.


EssilorLuxottica Shares Hit Two-Year Low Despite Double-Digit Growth

Significant Drop Amidst Strong Quarterly Results

This Friday, EssilorLuxottica's share price reached a two-year low at 186.85 euros, wiping out the previous floor of 186.80 euros recorded in 2024. This price level contrasts with the announcement on Wednesday, April 22, of a quarterly revenue of 7,127 million euros, up 10.8% at constant exchange rates, marking a third consecutive quarter of double-digit growth. Despite this, the group's strategy, backed by its optics activities, innovation in wearables, and the expansion of its global distribution network, continues to deliver robust commercial results. The stock has lost 27.38% over the past year and 9.69% over the last seven days. It now trades well below its 50-day moving average (212.87 euros) and 200-day moving average (260.88 euros), indicating a firmly established downward trend. The RSI, at 38, is approaching the oversold zone without having entered it yet, while the stock hovers near the lower Bollinger band (186.33 euros), confirming potential bearish excess. The general assembly scheduled for April 28 could be the next catalyst for the stock.

Investment Banks Reaffirm Confidence Despite Sharp Decline

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Despite the marked decline, two major investment banks reaffirmed their confidence in the stock yesterday. UBS adjusted its price target from 315 to 312 euros while maintaining its buy recommendation. Morgan Stanley reduced its target more significantly, from 365 to 315 euros, but continues to rate the stock as overweight. At current levels, these targets suggest a revaluation potential of between 67% and 69% compared to this morning's price, an unusually high gap that reflects the divergence between the fundamentals perceived by analysts and the stock's market trajectory. On the Parisian market, other major luxury and consumer goods stocks are also under pressure this Friday: LVMH is down 1.67% and L'Oréal by 0.78% during the session. Geopolitical tensions in the Middle East, which are driving Brent crude above 106 dollars, weigh on the entire market by reviving inflation fears and pushing away the prospect of cuts in key interest rates. This deteriorated macroeconomic climate constitutes an additional headwind for growth stocks like EssilorLuxottica, whose valuation multiples are particularly sensitive to changes in interest rates.



Sector Luxe Fournitures Médicales


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 28 491 millions d'euros
  • Revenue growth: 11,2 %
  • EBITDA: 6 492 millions d'euros
  • EBITDA margin: 22,8 %
  • Net income: 2 443 millions d'euros
  • Free cash flow: 2 796 millions d'euros
  • Net debt: 10 853 millions d'euros
  • Dividend per share: 4,00 euros
Guidance from the release
  • C’est une année historique pour EssilorLuxottica : pour la première fois depuis l’origine du Groupe, notre chiffre d’affaires a enregistré une croissance à deux chiffres à taux de change constant, après un quatrième trimestre affichant une croissance record de 18,4 %.
  • Résultats annuels 2025 marquent une croissance du chiffre d’affaires de 11,2% et une marge opérationnelle ajustée de 15,7%; le cash-flow libre atteint 2,8 milliards d'euros; dividende proposé de 4,00 euros; acquisitions et initiatives med-tech renforcent le positionnement.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit